Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Clene Inc.

Market Cap 76.8M 66.96M 62.02M 58.05M 109M 7.25B 110M 736M 285M 3.57B 288M 282M 12.38B P/E 2026 *
-3.37x
P/E 2027 * -4.08x
Enterprise Value 63.4M 55.28M 51.19M 47.92M 89.88M 5.98B 90.42M 607M 235M 2.94B 238M 233M 10.22B EV / Sales 2026 *
306x
EV / Sales 2027 * 2.34x
Free-Float
82.94%
Yield 2026 *
-
Yield 2027 * -
1 day+1.35%
1 week+2.91%
Current month-8.38%
1 month-5.80%
3 months+2.39%
6 months-10.03%
Current year+2.39%
1 week 5.5
Extreme 5.5
6.14
1 month 5.25
Extreme 5.25
6.93
Current year 3.88
Extreme 3.88
8.67
1 year 3.25
Extreme 3.25
13.5
3 years 2.28
Extreme 2.2801
20
5 years 2.28
Extreme 2.2801
356.4
10 years 2.28
Extreme 2.2801
356.4
Manager TitleAgeSince
Chief Executive Officer 59 31/03/2013
Chief Tech/Sci/R&D Officer 67 31/12/2012
Director of Finance/CFO 57 31/01/2022
Director TitleAgeSince
Chairman 65 31/10/2015
Director/Board Member 53 31/08/2019
Director/Board Member 49 30/11/2020
Date Insider Type Main position Quantity % Market Cap.
06-10Free

Chief Financial Officer

15,000 0.1174%
06-10Free

Chief Executive Officer

65,000 0.5087%
06-10Free

Founder

45,000 0.3522%
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%+2.91%+37.53%-64.73% 76.8M
+1.44%-1.25%+63.52%+114.88% 54.44B
+4.60%+3.02%+58.20%+47.16% 45.8B
-1.44%+0.39%-12.94%-19.24% 22.98B
-2.69%-2.10%-3.68%+379.00% 20.76B
+3.22%-0.84%+27.88%-34.00% 16.25B
+0.58%+1.08%+16.73%-38.06% 15.34B
-1.01%-2.30%+27.42%+171.92% 13.05B
+3.07%+0.14%+29.37% - 12.37B
+4.95%+11.70%+123.63%+252.19% 12.47B
Average +1.41%+2.88%+36.77%+89.90% 21.35B
Weighted average by Cap. +1.63%+1.49%+40.86%+99.85%

Financials

2026 *2027 *
Net sales 207K 181K 167K 157K 294K 19.57M 296K 1.99M 770K 9.63M 779K 762K 33.45M 23.64M 20.62M 19.09M 17.87M 33.52M 2.23B 33.72M 227M 87.78M 1.1B 88.75M 86.85M 3.81B
Net income -25.09M -21.88M -20.26M -18.97M -35.58M -2.37B -35.79M -240M -93.17M -1.17B -94.19M -92.17M -4.05B -27.55M -24.02M -22.25M -20.82M -39.06M -2.6B -39.29M -264M -102M -1.28B -103M -101M -4.44B
Net Debt -13.4M -11.68M -10.82M -10.13M -19M -1.26B -19.11M -128M -49.75M -622M -50.3M -49.22M -2.16B -21.4M -18.66M -17.28M -16.18M -30.34M -2.02B -30.52M -205M -79.45M -994M -80.33M -78.61M -3.45B
Logo Clene Inc.
Clene Inc. is a clinical-stage pharmaceutical company, which is engaged in discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities that do not present in those same elements in bulk form. CNM-Au8, the lead drug asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals for the treatment of ALS, MS, and PD. CNM-Au8's mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is an antiviral and antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions in an aqueous solution to treat infectious disease and to provide immune support for symptom resolution.
Employees
78
Date Price Change Volume
18/06/26 6.010 $ +1.35% 66,246
17/06/26 5.930 $ +1.37% 74,617
16/06/26 5.850 $ +1.39% 189,981
15/06/26 5.770 $ -1.20% 64,803
12/06/26 5.840 $ +5.61% 78,536
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.010USD
Average target price
32.20USD
Spread / Average Target
+435.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLNN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!